Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Open in API
Filings indexed 618 across all filing types
Latest filing 2016-01-29 Director's Dealing
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2016-01-29 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm to the SEC responding to a comment letter regarding a Registration Statement on Form S-1. It specifically addresses updating executive and director compensation disclosures as required by Regulation S-K Item 402 for the fiscal year ended December 31, 2015. The document is correspondence related to a regulatory filing and does not contain financial statements, audit results, or detailed report content. It is not a full report but a response to SEC comments on a registration statement. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and correspondence that do not fit other categories.
2016-01-19 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is a preliminary prospectus related to the registration of common stock for sale by a selling stockholder. The document includes detailed information about the company, the offering, risk factors, use of proceeds, management discussion and analysis, business description, and other disclosures typical of a registration statement for an initial or secondary public offering. This type of filing is related to capital raising activities and financing updates rather than financial results, management changes, or other report types. Therefore, the document fits the category of Capital/Financing Update filings.
2016-01-19 English
Regulatory Filings 2016
Regulatory Filings
2016-01-12 English
Director's Dealing 2016
Director's Dealing
2016-01-11 English
4 Filing
Director's Dealing
2016-01-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.